1. Home
  2. JCSE vs RNAZ Comparison

JCSE vs RNAZ Comparison

Compare JCSE & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JCSE
  • RNAZ
  • Stock Information
  • Founded
  • JCSE 1999
  • RNAZ 2016
  • Country
  • JCSE Singapore
  • RNAZ United States
  • Employees
  • JCSE N/A
  • RNAZ N/A
  • Industry
  • JCSE Miscellaneous manufacturing industries
  • RNAZ Biotechnology: Pharmaceutical Preparations
  • Sector
  • JCSE Consumer Discretionary
  • RNAZ Health Care
  • Exchange
  • JCSE Nasdaq
  • RNAZ Nasdaq
  • Market Cap
  • JCSE 5.9M
  • RNAZ 6.1M
  • IPO Year
  • JCSE 2022
  • RNAZ 2021
  • Fundamental
  • Price
  • JCSE $0.90
  • RNAZ $10.79
  • Analyst Decision
  • JCSE
  • RNAZ Strong Buy
  • Analyst Count
  • JCSE 0
  • RNAZ 1
  • Target Price
  • JCSE N/A
  • RNAZ $280.00
  • AVG Volume (30 Days)
  • JCSE 10.5K
  • RNAZ 249.9K
  • Earning Date
  • JCSE 05-15-2025
  • RNAZ 08-14-2025
  • Dividend Yield
  • JCSE 9.99%
  • RNAZ N/A
  • EPS Growth
  • JCSE N/A
  • RNAZ N/A
  • EPS
  • JCSE 0.00
  • RNAZ N/A
  • Revenue
  • JCSE $14,126,397.00
  • RNAZ N/A
  • Revenue This Year
  • JCSE N/A
  • RNAZ N/A
  • Revenue Next Year
  • JCSE N/A
  • RNAZ N/A
  • P/E Ratio
  • JCSE $195.99
  • RNAZ N/A
  • Revenue Growth
  • JCSE 6.92
  • RNAZ N/A
  • 52 Week Low
  • JCSE $0.86
  • RNAZ $6.15
  • 52 Week High
  • JCSE $2.39
  • RNAZ $739.20
  • Technical
  • Relative Strength Index (RSI)
  • JCSE 34.60
  • RNAZ 51.01
  • Support Level
  • JCSE $1.04
  • RNAZ $10.45
  • Resistance Level
  • JCSE $1.00
  • RNAZ $11.75
  • Average True Range (ATR)
  • JCSE 0.04
  • RNAZ 1.05
  • MACD
  • JCSE -0.01
  • RNAZ -0.13
  • Stochastic Oscillator
  • JCSE 0.00
  • RNAZ 16.45

About JCSE JE Cleantech Holdings Limited

JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The product lives of its cleaning systems and other equipment ranges from two to ten years. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. The company derives the majority of its revenue from the Sales of cleaning systems and other equipment. Geographically, the company derives a majority of its revenue from Singapore, followed by Malaysia.

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.

Share on Social Networks: